SCHEMBL4861150

SCHEMBL4861150

CC1C(=O)C(C(O)/C=C/c2ccccc2)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GPR119 Q8TDV5 2/20 0.40
HSD17B2 P37059 1/20 0.38
GRM5 P41594 3/20 0.37
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
GABBR2 O75899 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRB2 P47870 1/20 0.35
GABBR1 Q9UBS5 1/20 0.35
NPC1 O15118 1/20 0.35
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
MAPK1 P28482 1/20 0.35
STS P08842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4861156 1.00 MEN1 (0.42) MEN1ALDH1A1LMNATSHRKMT2A
SCHEMBL4870167 0.86 HSD17B2 (0.39) MEN1LMNAKMT2AHSD17B2GABBR2
SCHEMBL4870175 0.86 HSD17B2 (0.39) MEN1LMNAKMT2AHSD17B2GABBR2
SCHEMBL4870111 0.82 NPC1 (0.35) MEN1KMT2AGRM5KDM4ENPC1
SCHEMBL30296405 0.72 GPR119 (0.37) MEN1ALDH1A1LMNATSHRKMT2A
SCHEMBL4775801 0.72 KDM4E (0.42) MEN1ALDH1A1LMNATSHRKMT2A
SCHEMBL6012032 0.72 MEN1 (0.53) MEN1ALDH1A1LMNATSHRKMT2A
SCHEMBL3052925 0.72 MEN1 (0.53) MEN1ALDH1A1LMNATSHRKMT2A
SCHEMBL3052928 0.72 MEN1 (0.53) MEN1ALDH1A1LMNATSHRKMT2A
SCHEMBL7991114 0.71 GPR119 (0.53) MEN1ALDH1A1KMT2AL3MBTL1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388019-B2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes MERCK & CO., INC. (US) 2008-06-17 US disclosed
US-20060074087-A1 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes MERCK SHARP & DOHME LLC 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074087-A1 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes DPP4, DPP3, DPP7 MEN1 4771/4885ALDH1A1 686/4885LMNA 3093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.